BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)

Clinical trial NCT02204072 · COMPLETED

Trial details

NCT number: NCT02204072
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Neoplasms, Castration-Resistant

Start date: 2014-11-11
Primary completion: 2019-10-18
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.